Synapse News
Lactiga Receives FDA ‘Rare Pediatric Disease’ Designation for Groundbreaking Mucosal Immunoglobulin Therapy for CVID
LCTG-001 on course to be the first FDA-approved biologic from human milk for pediatric patients with Common Variable Immunodeficiency.
PreOperative Performance Enters the SOPHIE Program to Fuel Collaboration with Ontario-Based Radiology Researchers
Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research Institute of St. Joe’s Hamilton (RSJH) to evaluate technology that aims to help radiology groups make better quality measurements of MRI machines. This press release was originally shared by PreOperative Performance…
Fusion Pharmaceuticals Announces IND Clearance For FPI-2068, A Jointly Developed Novel Targeted Alpha Therapy
This press release was originally published by Fusion Pharmaceuticals on April 12, 2023. Read the original post here. FPI-2068 is a Bispecific Targeted Alpha Therapy (TAT) designed to Precisely Deliver Radiation to Tumor Cells HAMILTON, ON and BOSTON, April 12, 2023 /– Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage…
Vessl Prosthetics Inc. takes first place in 10th Annual Synapse Competition, Winning over 50k in cash and in-kind prizes
Hamilton, ON – March 23, 2023 – Yesterday, Innovation Factory’s Synapse Life Science Competition, Ontario’s premier life science pitch competition, announced the winners of over $100,000 in prizes at the 10th annual showcase event. After three years of virtual events, the competition was held in person for the first time since 2019,…
Altis Labs leads $6 million pan-Canadian initiative to develop and commercialize imaging biomarkers using deep learning
This media release was originally published by Altis Labs on January 24, 2023. Toronto, Ontario – Altis Labs, Inc. (“Altis”), the computational imaging platform for advancing precision medicine, announces today an initiative focused on developing, validating, and commercializing fully automated imaging biomarkers for solid tumors using…
Canadian Venture Capital-Funded Biotech Companies to Watch in 2023
This article was originally published by Back Bay Life Science Advisors on February 1, 2023. Canada’s thriving life science economy: spanning biotechnology/pharmaceuticals, medical devices, and digital health, consists of around 6,000 organizations and employs 120,000 people 1. The biotechnology and pharmaceutical industries…
Evolving a Novel Approach to Cell-Based Therapies with Hamilton’s Renowned Medical Innovation Ecosystem
A trained opera singer with an accomplished business background and a professor of chemistry, renowned globally for his research and expertise, may not appear to have anything in common. Yet a shared passion for innovation, a desire to make a difference and the knowledge of an unmet need in medical treatment options, led Maria Antonakos […]
McMaster researchers receive $61 million from CIHR to advance health research
This article was first published on Brighter World – McMaster University. Read the original article. Seven McMaster-led research projects have received a total of $61 million from the Canadian Institutes of Health Research (CIHR) to advance medical research, training and innovation. The announcement was made at McMaster by Filomena…
From Innovator to Enabler, MedStack sees Traction with its Digital Health Platform
Healthcare is important and we all depend on it. Governments want an efficient system that operates at a low cost. Healthcare practitioners want to provide the best level of service possible while minimizing clinician burnout. Patients want access to quality care whenever they or a loved one needs it. In recent years, as organizations and…